Are MS and ALS Caused by Autoimmunity Against the Brain's Own Neuropeptides?

Autoimmunity against endogenous vasoactive neuropeptides (VIP, PACAP, CGRP) is proposed as a pathogenic mechanism for MS and ALS, with evidence of anti-neuropeptide antibodies in these patients.

Staines, Donald R·Medical hypotheses·2008·Preliminary EvidenceReview
RPEP-01423ReviewPreliminary Evidence2008RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Autoimmune attack on endogenous vasoactive neuropeptides (VIP, PACAP, CGRP) is proposed as a pathogenic mechanism for MS and ALS, with detection of anti-neuropeptide antibodies and correlation with disease activity — neuropeptide autoimmunity as neurodegeneration cause.

Key Numbers

How They Did This

review study.

Why This Research Matters

Relevant for neuropeptides, neuroprotection, immune-function.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Autoimmune attack on endogenous vasoactive neuropeptides (VIP, PACAP, CGRP) is proposed as a pathogenic mechanism for MS and ALS, with detection of an
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2008.
Original Title:
Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?
Published In:
Medical hypotheses, 70(2), 413-8 (2008)
Authors:
Staines, Donald R(3)
Database ID:
RPEP-01423

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Are MS and ALS Caused by Autoimmunity Against the Brain's Own Neuropeptides?

What was found?

Autoimmunity against endogenous vasoactive neuropeptides (VIP, PACAP, CGRP) is proposed as a pathogenic mechanism for MS and ALS, with evidence of anti-neuropeptide antibodies in these patients.

Read More on RethinkPeptides

Cite This Study

RPEP-01423·https://rethinkpeptides.com/research/RPEP-01423

APA

Staines, Donald R. (2008). Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?. Medical hypotheses, 70(2), 413-8.

MLA

Staines, Donald R. "Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?." Medical hypotheses, 2008.

RethinkPeptides

RethinkPeptides Research Database. "Are multiple sclerosis and amyotrophic lateral sclerosis aut..." RPEP-01423. Retrieved from https://rethinkpeptides.com/research/staines-2008-are-multiple-sclerosis-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.